24 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert
Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Upjohn
Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Nagasaki International University
Novel low molecular renin inhibitors which show good oral blood pressure lowering effects in marmosets![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
MDL 74147, a novel selective and soluble inhibitor of human renin. Synthesis, structure-activity relationship, species and protease selectivities.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere template.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Pfizer
Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3- [[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-725![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Abbott Laboratories
Nonpeptide renin inhibitors with good intraduodenal bioavailability and efficacy in dog.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Abbott Laboratories
Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Abbott Laboratories
Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
Synthesis and biological activity of some transition-state inhibitors of human renin.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Ciba-Geigy
New human renin inhibitors containing an unnatural amino acid, norstatine.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Kissei Pharmaceutical
Inhibitors of human renin. Cyclic peptide analogues containing a D-Phe-Lys-D-Trp sequence.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Ici Pharmaceuticals Group
Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Takeda Pharmaceutical